DOI QR코드

DOI QR Code

황련감초 추출물의 상피지방장벽 생성을 통한 Th2 분화 조절

Effect of Th2 Differentiation Control through Formation of Skin Fat Barrier on Coptidis Rhizoma & Glycyrrhiza Uralensis extract

  • 박범찬 (부산대학교한방병원 한방소아과) ;
  • 안상현 (세명대학교 한의과대학 해부학교실) ;
  • 서일복 (세명대학교 한의과대학 해부학교실) ;
  • 천진홍 (부산대학교한방병원 한방소아과) ;
  • 김기봉 (부산대학교한방병원 한방소아과)
  • Park, Beom Chan (Department of Korean Pediatrics, Pusan National University Korean Medicine Hospital) ;
  • Ahn, Sang Hyun (Department of Anatomy, College of Korean Medicine, Semyung University) ;
  • Seo, Il Bok (Department of Anatomy, College of Korean Medicine, Semyung University) ;
  • Cheon, Jin Hong (Department of Korean Pediatrics, Pusan National University Korean Medicine Hospital) ;
  • Kim, Ki Bong (Department of Korean Pediatrics, Pusan National University Korean Medicine Hospital)
  • 투고 : 2020.07.24
  • 심사 : 2020.08.22
  • 발행 : 2020.08.31

초록

Objectives This study is conducted to evaluate Th2 skewed condition control through skin fat barrier formation from the treatment using Coptidis Rhizoma and Glycyrrhiza uralensis extract. Methods The 6-week-old NC/Nga mice were divided into 4 groups: Control group (Ctrl), lipid barrier eliminate treatment group (LBET), Coptidis Rhizoma and Glycyrrhiza uralensis feeding treatment after lipid barrier elimination group (CGFT), dexamethasone feeding treatment after lipid barrier elimination group (DxFT). After 3 days, differences in skin condition, improvement of skin fat barrier, and control of Th2 skewed condition of each group were observed. Results Pathologic skin damage and tissue changes were less in the CGFT group than in the LBET and DxFT groups, and Transepidermal water loss (TEWL) and pH were also significantly decreased (p < 0.05). The filaggrin intensity and positive response also increased significantly in the CGFT group (p < 0.05). Kallikrein-related peptidase (KLK) 7, Protease activated receptor (PAR)-2, Thymic stromal lymphopoietin (TSLP), Interleukin (IL)-4, and the products of the Th2 differentiation process also showed a significant decrease compared to the LBET and DxFT groups (all p < 0.05). Conclusions The Coptidis Rhizoma and Glycyrrhiza uralensis extract causes skin barrier recovery and function recovery through the formation of skin fat barrier. This leads to the conclusion that Coptidis Rhizoma and Glycyrrhiza uralensis extract can control Th2 differentiation through the formation of skin fat barrier.

키워드

참고문헌

  1. Ko WS, Kim KJ, Kim NK, Kim YB, Kin JH, Kim HT, Nam HJ, Park MC, Park SY, Seo HS, Yoon HJ, Lee SG, Lim GS, Ji SY, Choi JH, Choi IH, Hong SH, Hong SW, Hwang CY. Text of Traditional Korean Dermatology & Surgery. Pusan: Sunwoo; 2007. 37-48p
  2. Kim YJ, Ahn JY, Seo SJ, Hong CK. The effect of retinoic acid on expression of human beta defensin-2 and LL-37 in keratinocyte. J Korean Invest Dermatol. 2007;14(1):29-35.
  3. Kwon MS, Choi TB, Kim GY. The effect on the skin barrier function of ceramide. Korean J Aesthet Soc. 2005;3(1):131-7.
  4. Kim BB, Kim JR, Kim JH, Kim YA, Park JS, Yeom MH, Lee HJ, Lee KW, Kang NJ. 7,3',4'-Trihydroxyisoflavone ameliorates the development of Dermatophagoides farinae-induced atopic dermatitis in NC/Nga mice. Evid Based Complement Alternat Med. 2013;2013:1-10.
  5. Kelleher M, Galvin AD, Hourihane JOB, Murray D, Campbell LE, McLean WHI, Irvine AD. Skin barrier dysfunction measured by transepidermal water loss at 2 days and 2 months predates and predicts atopic dermatitis at 1 year. J Allergy Clin Immunol. 2015;135(4):930-5.e1. https://doi.org/10.1016/j.jaci.2014.12.013
  6. Kim IR, Kim HC, Kook YB, Park SJ, Park YK, Park JH, Seo BI, Seo YB, Song HJ, Lee YJ, Lee YC, Lee JH, Lim KH, Cho SI, Jeong JK, Joo YS, Choi HY. Text of Herbology. Seoul: Yonglimsa; 2012. 218-20p, 584-6p.
  7. Kim HK, Hong SU. The anti-inflammatory effects of Huang-Lyun (Coptidis Rhizoma, CR) on injured tissue after burn elicitation. J Korean Oriental Med. 2011;32(2):1-13.
  8. Jeong AR, Ahn SH, Jeong HS, Kim KB. Effect of Coptidis Rhizoma extract on atopic dermatitis-like skin lesions in NC/Nga mice. J Physiol & Pathol Korean Med 2019;33(2):102-8. https://doi.org/10.15188/kjopp.2019.04.33.2.102
  9. Kim NW, Seo SJ, Park GR, Lee YS. Anti-wrinkle and antioxidant activity of 1,3-butylene glycol mixed extracts from coptidis rhizoma. J Invest Cosmeto. 2018;14(3):267-76.
  10. Cho HJ, Lim SS, Lee YS, Kim JS, Lee CH, Kwon DY, Park HY. Hexane/ethanol extract of Glycyrrhiza uralensis licorice exerts potent anti-inflammatory effects in murine macrophages and in mouse skin. Food Chem. 2010;121(4):959-66. https://doi.org/10.1016/j.foodchem.2010.01.027
  11. Ahn SH, Kim KB. Effect of skin fat lipid barrier formation on hataedock with coptis japonica & glycyrrhiza uralensis. J Pediatr Korean Med. 2017;31(3):14-23. https://doi.org/10.7778/jpkm.2017.31.3.014
  12. Forslind B. A domain mosaic model of the skin barrier. Acta Derm Venereol. 1994;74(1):1-6.
  13. Kwon YB, Choi DK, Sohn KC, Jeon EK, Nam MS, Lee JH, Kim CD. Effects of colostrum on keratinocyte differentiation and wound healing. Korean J Invest Dermatol. 2007;14(2):45-50.
  14. Kim HJ, Jeong SK, Yum HY, Lee SH. Atopic dermatitis dermatological understanding and integrated treatment. Kor Soc Skin Barrier Res. 2010;12(1):67-78.
  15. Kim JT, Park IS, Ahn SH. Delayed type hypersensitivity on abdominal skin of mouse by DNCB sensitization. DJIOM. 1997;6(1):117-28.
  16. Fluhr JW, Kao J, Jain M, Ahn SK, Feingold KR, Elias PM. Generation of free fatty acids from phospholipids regulates stratum corneum acidification and integrity. J Invest Dermatol. 2001;117(1):44-51. https://doi.org/10.1046/j.0022-202x.2001.01399.x
  17. Lee SI, Ahn KM, Kim JH, Kim JH, Kim HY, Park SH, Park YM, Park HY, Seo WH, Seo JM, Yoo JS, Lee JH, Lee HS, Jeong YH, Jeong JA, Jo JB, Han YS. Atopic Disease Prevention and Management General Report. Seoul: Atopy Environmental Health Center at Samsung Medical Center; 2012. 95p.
  18. Rogiers V. EEMCO Guidance for the assessment of transepidermal water loss in cosmetic sciences. Skin Pharmacol Appl Skin Physiol. 2001;14(2):117-28. https://doi.org/10.1159/000056341
  19. Lambers H, Piessens S, Bloem A, Pronk H, Finkel P. Natural skin surface pH is on average below 5, which is beneficial for its residential flora. Int J Cosmet Sci. 2006;28(5):359-70. https://doi.org/10.1111/j.1467-2494.2006.00344.x
  20. Kim HJ, Shin JU, Lee KH. Atopic dermatitis and skin barrier dysfunction. Allergy Asthma Respir Dis. 2013;1(1):20-8. https://doi.org/10.4168/aard.2013.1.1.20
  21. Choi EH, Yoon NY. Pathogenesis of atopic dermatitis. J Korean Med Assoc 2014; 57(3): 218-225. https://doi.org/10.5124/jkma.2014.57.3.218
  22. Kim HJ, Lee SH. The effect of skin surface on epidermal permeability barrier. J Skin Barrier Res. 2008;10(1):44-55.
  23. Chen JQ, Liang BH, Li HP, Mo ZY, Zhu HL. Roles of kallikrein-related peptidase in epidermal barrier function and related skin diseases. Int J Dermatol Venereol. 2019;2(3):150-5. https://doi.org/10.1097/JD9.0000000000000036
  24. Yamamoto M, Miyai M, Matsumoto Y, Tsuboi R, Hibino T. Kallikrein-related peptidase-7 regulates caspase-14 maturation during keratinocyte terminal differentiation by generating an intermediate form. J Biol Chem 2012;287(39):32825-32834. https://doi.org/10.1074/jbc.M112.357467
  25. Yosipovitch G, Papoiu AD. What causes itch in atopic dermatitis? Curr Allergy Asthma Rep 2008;8:306-11. https://doi.org/10.1007/s11882-008-0049-z
  26. Briot A, Deraison C, Lacroix M, Bonnart C, Robin A, Besson C, Dubus P, Hovnanian A. Kallikrein 5 induces atopic dermatitislike lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome. J Exp Med 2009;206(5):1135-47. https://doi.org/10.1084/jem.20082242
  27. Demerjian M, Hachem JP, Tschachler E, Denecker G, Declercq W, Vandenabeele P, Mauro T, Hupe M, Crumrine D, Roelandt T, Houben E, Elias PM, Feingold KR. Acute modulations in permeability barrier function regulate epidermal cornification: role of caspase-14 and the protease-activated receptor type 2. Am J Pathol 2008;172(1):86-97. https://doi.org/10.2353/ajpath.2008.070161
  28. Hatano Y, Terashi H, Arakawa S, Katagiri K. Interleukin-4 suppresses the enhancement of ceramide synthesis and cutaneous permeability barrier functions induced by tumor necrosis factor-alpha and interferon- gamma in human epidermis. J Invest Dermatol 2005;124(4):786-92. https://doi.org/10.1111/j.0022-202X.2005.23651.x
  29. Kim BE, Leung DY, Boguniewicz M, Howell MD. Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6. Clin Immunol 2008;126(3):332-7. https://doi.org/10.1016/j.clim.2007.11.006
  30. Albanesi C, Fairchild HR, Madonna S, Scarponi C, De Pita O, Leung DY, Howell MD. IL-4 and IL-13 negatively regulate TNF-alpha- and IFN-gamma-induced beta-defensin expression through STAT-6, suppressor of cytokine signaling (SOCS)-1, and SOCS-3. J Immunol 2007;179(2):984-92. https://doi.org/10.4049/jimmunol.179.2.984